HRS 3797
Alternative Names: HRS-3797Latest Information Update: 15 Jun 2023
At a glance
- Originator Fujian Shengdi Pharmaceutical
- Class Muscle relaxants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Muscle fatigue
Most Recent Events
- 15 Jun 2023 Fujian Shengdi Pharmaceutical completes the phase I trial in Muscle fatigue (In adults, In volunteers) in China (NCT05701826)
- 15 Feb 2023 Phase-I clinical trials in Muscle fatigue (In adults, In volunteers) in China (IV) (NCT05701826)
- 27 Jan 2023 Fujian Shengdi Pharmaceutical plans a phase I trial for muscle fatigue (In adults, In the elderly, In volunteers) (NCT05701826)